Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Jia Jie Biomedical Co's Revenue for the
three
months ended in Jun. 2026 was NT$133.0 Mil. Jia Jie Biomedical Co's average Accounts Receivable for the
three
months ended in Jun. 2026 was NT$42.9 Mil.
Hence, Jia Jie Biomedical Co's Receivables Turnover for the
three
months ended in Jun. 2026 was 3.10.
Jia Jie Biomedical Co (ROCO:4109) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Jia Jie Biomedical Co Receivables Turnover Related Terms
Jia Jie Biomedical Co Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Jia Jie Biomedical Co's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4109 vs KHC, GIS: Receivables Turnover Comparison
For the Packaged Foods subindustry, Jia Jie Biomedical Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jia Jie Biomedical Co Receivables Turnover vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jia Jie Biomedical Co's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Jia Jie Biomedical Co's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jia Jie Biomedical Co (ROCO:4109) has a Receivables Turnover of 3.10 as of Jun. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Jia Jie Biomedical Co and its competitors. According to the industry distribution chart, Jia Jie Biomedical Co ranks #682 out of 1946 companies in the Consumer Packaged Goods industry, placing it in the top 35%.
Is Jia Jie Biomedical Co's Receivables Turnover too high?
Jia Jie Biomedical Co's current Receivables Turnover is 3.10. The Consumer Packaged Goods industry median Receivables Turnover is 9.38. Jia Jie Biomedical Co's value of 3.10 is 67% below this industry median. Based on the distribution chart, Jia Jie Biomedical Co ranks #682 out of 1946 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Jia Jie Biomedical Co has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's Receivables Turnover compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Jia Jie Biomedical Co ranks #682 out of 1946 companies for Receivables Turnover. This puts Jia Jie Biomedical Co in the upper half of its industry. The industry median Receivables Turnover is 9.38. Jia Jie Biomedical Co's value of 3.10 is 67% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Consumer Packaged Goods company?
The median Receivables Turnover among Consumer Packaged Goods companies is 9.38, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jia Jie Biomedical Co's current Receivables Turnover of 3.10 is 67% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Jia Jie Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median Receivables Turnover is 9.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jia Jie Biomedical Co's current Receivables Turnover is 3.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$15.98, compared to a current price of NT$11.20 — trading 29.9% below its estimated fair value. The current Receivables Turnover is 3.10 and 67% below the Consumer Packaged Goods industry median of 9.38. Jia Jie Biomedical Co's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current Receivables Turnover is 3.10 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?
Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued.
The current stock price of NT$11.20 is trading 29.9% below its estimated GF Value™ of NT$15.98.
GuruFocus considers Jia Jie Biomedical Co to be Significantly Undervalued.
Key valuation signals for ROCO:4109:
Receivables Turnover: 3.10
GF Value™: NT$15.98 vs. price of NT$11.20 (29.9% below fair value)
Industry Position: 67% below the Consumer Packaged Goods median (#682 of 1946)
No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
67GF Score
Get the complete analysis for ROCO:4109
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4109 has been successfully added to your 
